Results 1 to 10 of about 6,300 (176)
Budd-Chiari syndrome from pleomorphic sarcoma compressing the inferior vena cava: A case report [PDF]
Budd-Chiari syndrome is a rare condition characterized by obstruction of the hepatic veins or inferior vena cava, leading to portal hypertension and liver dysfunction. While common etiologies include thrombosis or malignancy, we present, to our knowledge,
Brandon Camp, BS +5 more
doaj +2 more sources
A Rare Case of Budd–Chiari Syndrome in a Young Female [PDF]
Budd–Chiari syndrome is a rare disorder characterized by hepatic vein obstruction, with an incidence of 1 in 100,000. It can be diagnosed through imaging studies and initially managed with anticoagulants.
Joshua Chacko +5 more
doaj +2 more sources
Review of Budd-Chiari Syndrome
This study aims to report the Budd-Chiari syndrome clinical research status and progress that has occurred in over nearly 30 years in China, and emphasize the value of imaging in facilitating the diagnosis of Budd-Chiari syndrome based on more than 2500 ...
Maoheng Zu +7 more
doaj +3 more sources
Budd-Chiari syndrome (BCS) is a rare disease with an incidence of 0.1 to 10 per million inhabitants a year caused by impaired venous outflow from the liver mostly at the level of hepatic veins and inferior vena cava. Etiological factors include hypercoagulable conditions, myeloprolipherative diseases, anatomical variability of the inferior vena cava ...
Tomáš Grus +4 more
openaire +4 more sources
BackgroundFerroptosis is one of the main mechanisms of sorafenib against hepatocellular carcinoma (HCC). Epithelial-mesenchymal transition (EMT) plays an important role in the heterogeneity, tumor metastasis, immunosuppressive microenvironment, and drug ...
Zhaochen Liu +17 more
doaj +1 more source
Budd- Chiari Syndrome as an Initial Manifestation of Systemic Lupus Erythematosus [PDF]
Budd- Chiari syndrome is caused by obstruction of hepatic venous outflow. There are numerous causes for Budd-Chiari syndrome. One of the causes is systemic lupus erythematosus due to antiphospholipid antibodies.
Jayabal Pandiaraja +1 more
doaj +1 more source
Budd‐Chiari syndrome (BCS) is a rare and potentially life‐threatening disorder characterized by obstruction of the hepatic outflow tract at any level between the junction of the inferior vena cava with the right atrium and the small hepatic veins. In the West, BCS is a rare hepatic manifestation of one or more underlying prothrombotic risk factors. The
Pieter, Martens, Frederik, Nevens
openaire +2 more sources
Factor V G1691A (Leiden) is a major etiological factor in Egyptian Budd-Chiari syndrome patients
OBJECTIVE: Budd-Chiari syndrome is a multifactorial disease in which several prothrombotic disorders may predispose patients to the development of thrombosis at this uncommon location (hepatic veins). The aim of this study was to determine the prevalence
Tawhida Y. Abdel Ghaffar +7 more
doaj +3 more sources
Primary Budd-Chiari syndrome is related to thrombosis of hepatic veins or the terminal portion of the inferior vena cava. This rare disease is usually caused by multiple concurrent factors, including acquired and inherited thrombophilias. Half of the patients with primary Budd-Chiari syndrome are affected with a myeloproliferative disease, the ...
Aurélie, Plessier +1 more
openaire +3 more sources
Hepatic venous outflow block in a young patient with Systemic Lupus Erythematosus [PDF]
Introduction: Hepatic venous outflow block or Budd-Chiari syndrome is a severe liver disease with a 3 years survival rate of 50%. Several conditions have been implicated as a cause of Budd-Chiari syndrome, including myeloproliferative disorders ...
Ali Ghavidel
doaj +1 more source

